Issuer directory · Biotechnology · page 5
Biotechnology: issuers 401 to 500 of 832.
Ranked by the amount reported sold on the newest Form D. Page 1 holds the largest raises in the group.
| Issuer | Reported sold | Investors | Exemption | Newest notice | Filings | Platform |
|---|---|---|---|---|---|---|
| Cloverleaf Bio, Inc. | $14.8M | 12 | 506(b) | Sep 9, 2026 | 1 | direct |
| Medici Therapeutics, Inc. | $14.8M | 11 | 506(b) | Dec 4, 2025 | 1 | direct |
| Model Medicines, Inc. | $14.8M | 43 | 506(b) | Oct 15, 2024 | 1 | direct |
| TYBR Health, Inc. | $14.4M | 12 | 506(b) | Jul 22, 2026 | 1 | direct |
| MAINZ BIOMED N.V. | $14.3M | 1 | 506(b) | May 10, 2024 | 2 | direct |
| Causeway Therapeutics Ltd | $14.3M | 10 | 506(b) | Feb 28, 2023 | 1 | direct |
| OUROTECH, INC.- PEAR BIO | $14.2M | 12 | 506(b) | Apr 14, 2023 | 1 | direct |
| Ray Therapeutics, Inc. | $14.0M | 13 | 506(b) | May 26, 2023 | 1 | direct |
| OncoResponse Inc | $13.9M | 13 | 506(b) | May 12, 2023 | 1 | direct |
| Anuncia Medical, Inc. | $13.9M | 87 | 506(b) | Nov 21, 2025 | 3 | direct |
| Remix Therapeutics, Inc. | $13.7M | 21 | 506(b) | Jan 4, 2024 | 1 | direct |
| Sensible Biotechnologies, Inc. | $13.5M | 15 | 506(b) | Sep 2, 2026 | 1 | direct |
| Parcel Biosciences, Inc. | $13.2M | 52 | 506(c) | Mar 4, 2026 | 1 | direct |
| Inflammasome Therapeutics, Inc. | $13.2M | 62 | 506(b) | May 4, 2026 | 1 | direct |
| Theriva Biologics, Inc. | $13.1M | 10 | 506(b) | Oct 24, 2025 | 1 | direct |
| ADAPTIN BIO, INC. | $13.1M | 95 | 506(b) | Feb 26, 2025 | 1 | direct |
| Valora Therapeutics, Inc. | $13.0M | 12 | 506(b) | Jul 24, 2024 | 1 | direct |
| Circulate Health, Inc. | $13.0M | 4 | 506(b) | Jan 9, 2026 | 2 | direct |
| Savanna Biotherapeutics, Inc. | $13.0M | 30 | 506(b) | Jun 30, 2025 | 1 | direct |
| Onconetix, Inc. | $13.0M | 11 | 506(b) | Oct 7, 2025 | 1 | direct |
| Chimeron Bio Corp | $12.8M | 9 | 506(b) | Mar 14, 2025 | 2 | direct |
| Alume Biosciences Inc | $12.8M | 43 | 506(b) | Jan 9, 2023 | 1 | direct |
| GRADALIS, INC. | $12.7M | 24 | 506(b) | Jun 12, 2025 | 1 | direct |
| TearSolutions, Inc. | $12.7M | 80 | 506(b) | Oct 9, 2024 | 1 | direct |
| OncoNano Medicine, Inc. | $12.7M | 25 | 506(b) | Jun 2, 2025 | 1 | direct |
| Diceros Therapeutics, Inc. | $12.6M | 13 | 506(b) | Aug 5, 2024 | 2 | direct |
| Xsphera Biosciences Inc | $12.6M | 40 | 506(b) | May 4, 2023 | 1 | direct |
| Dare Bioscience, Inc. | $12.4M | 12 | 506(b) | Aug 20, 2026 | 1 | direct |
| Revalia Bio, Inc. | $12.3M | 32 | 506(b) | Nov 6, 2024 | 1 | direct |
| Codetta Bio Inc. | $12.3M | 4 | 506(b) | Oct 30, 2024 | 2 | direct |
| Digital Biotechnologies, Inc. | $12.3M | 61 | 506(b) | Dec 31, 2025 | 1 | direct |
| 76Bio, Inc. | $12.2M | 32 | 506(b) | Feb 14, 2023 | 2 | direct |
| Automera US Inc. | $12.2M | 12 | 506(b) | Oct 17, 2024 | 2 | direct |
| Phantom Neuro Inc. | $12.1M | 22 | 506(b) | Mar 18, 2025 | 1 | direct |
| Dimension Inx Corp. | $12.0M | 17 | 506(b) | Feb 3, 2023 | 1 | direct |
| Cytonus Therapeutics, Inc. | $11.7M | 19 | 506(b) | Nov 6, 2023 | 1 | direct |
| Portal Biotechnologies, Inc. | $11.7M | 43 | 506(b) | May 29, 2026 | 2 | direct |
| Serimmune Inc. | $11.5M | 2 | 506(b) | Nov 15, 2023 | 5 | direct |
| Restora Medical, Inc. | $11.5M | 5 | 506(b) | Jun 18, 2026 | 2 | direct |
| Vetmab Biosciences, Inc. | $11.4M | 30 | 506(b) | Sep 29, 2026 | 1 | direct |
| Genialis, Inc. | $11.4M | 10 | 506(b) | Jan 31, 2023 | 1 | direct |
| Switchback Systems, Inc. | $11.3M | 8 | 506(b) | Aug 21, 2024 | 2 | direct |
| Orcosa Inc. | $11.3M | 36 | 506(b) | Jan 7, 2025 | 2 | direct |
| Pearl Diagnostics, Inc. | $11.2M | 21 | 506(b) | Apr 21, 2026 | 1 | direct |
| RenovoRx, Inc. | $11.1M | 172 | 506(b) | Apr 22, 2024 | 1 | direct |
| Bariendo Inc. | $11.1M | 21 | 506(b) | Apr 3, 2025 | 1 | direct |
| CALVIRI INC | $11.1M | 32 | 506(b) | May 9, 2023 | 2 | direct |
| PROXIMITY THERAPEUTICS, INC. | $11.0M | 9 | 506(b) | Jan 4, 2023 | 2 | direct |
| JW Celtics Investment Corp. | $11.0M | 15 | 506(b) | May 26, 2023 | 1 | direct |
| CrossBridge Bio, Inc. | $10.8M | 23 | 506(b) | Nov 4, 2024 | 1 | direct |
| Topo Therapeutics, Inc. | $10.6M | 4 | 506(b) | Dec 31, 2024 | 2 | direct |
| Project Samri Inc. | $10.5M | 18 | 506(b) | Nov 13, 2023 | 1 | direct |
| ELUTIA INC. | $10.5M | 12 | 506(b) | Oct 3, 2023 | 1 | direct |
| Modifi Biosciences, Inc. | $10.5M | 40 | 506(b) | Aug 3, 2023 | 2 | direct |
| Notable Labs, Inc. | $10.3M | 26 | 506(b) | Mar 8, 2023 | 1 | direct |
| Pulmotect, Inc. | $10.3M | 15 | 506(b) | Sep 9, 2024 | 1 | direct |
| Centrexion Therapeutics Corp | $10.3M | 124 | 506(b) | Jul 11, 2023 | 2 | direct |
| Blue Arbor Technologies, Inc. | $10.2M | 32 | 506(b) | Jul 27, 2026 | 1 | direct |
| ImmuneBridge Inc. | $10.2M | 15 | 506(b) | Jan 10, 2023 | 1 | direct |
| GRANATA BIO Corp | $10.1M | 10 | 506(b) | Nov 6, 2023 | 1 | direct |
| Medical 21, Inc. | $10.0M | 39 | 506(b) | Aug 21, 2025 | 4 | direct |
| Chemomab Therapeutics Ltd. | $10.0M | 10 | 506(b) | Aug 9, 2024 | 1 | direct |
| Scion Neurostim, Inc. | $10.0M | 13 | 506(b) | Oct 19, 2023 | 1 | direct |
| Orion Biotechnology Canada Ltd. | $9.9M | 114 | 506(b) | Mar 15, 2023 | 3 | direct |
| Mati Therapeutics Inc. | $9.9M | 13 | 506(b) | Oct 8, 2025 | 1 | direct |
| Hubble Therapeutics, LLC | $9.8M | 17 | 506(b) | Oct 21, 2024 | 1 | direct |
| SONALASENSE, INC. | $9.8M | 30 | 506(b) | Nov 6, 2023 | 1 | direct |
| Pluristyx Inc. | $9.8M | 13 | 506(b) | Jul 13, 2026 | 1 | direct |
| Lila Biologics, Inc. | $9.5M | 18 | 506(b) | Sep 28, 2023 | 1 | direct |
| ARTELO BIOSCIENCES, INC. | $9.5M | 18 | 506(b) | Aug 13, 2025 | 1 | direct |
| Perimetrics, Inc. | $9.4M | 118 | 506(b) | Nov 7, 2025 | 1 | direct |
| IVIEW Therapeutics, Inc. | $9.2M | 5 | 506(b) | Jun 10, 2025 | 3 | direct |
| CalciMedica, Inc. | $9.1M | 55 | 506(b) | Apr 4, 2023 | 1 | direct |
| EmpNia Inc. | $9.1M | 90 | 506(b) | Mar 6, 2026 | 2 | direct |
| Euphrates Vascular, Inc. | $9.1M | 33 | 506(b) | Oct 3, 2023 | 2 | direct |
| Carna Inc. | $9.1M | 27 | 506(b) | Jun 11, 2026 | 2 | direct |
| Navrogen Inc. | $9.1M | 20 | 506(b) | Feb 27, 2023 | 2 | direct |
| Starling Medical, Inc. | $8.9M | 40 | 506(b) | Dec 9, 2024 | 2 | direct |
| Corvia Medical, Inc. | $8.9M | 10 | 506(b) | Jun 25, 2025 | 1 | direct |
| Simergent, LLC | $8.8M | 57 | 506(b) | Mar 27, 2026 | 2 | direct |
| Eterna Therapeutics Inc. | $8.7M | 19 | 506(b) | Jul 26, 2023 | 1 | direct |
| Syenex, Inc. | $8.7M | 18 | 506(b) | Jan 27, 2025 | 1 | direct |
| CND Life Sciences, Inc. | $8.6M | 38 | 506(b) | May 6, 2025 | 3 | direct |
| 28bio, Inc. | $8.5M | 10 | 506(b) | Oct 29, 2026 | 3 | direct |
| AbbraTech Holdings LLC | $8.5M | 17 | 506(b) | Dec 6, 2023 | 1 | direct |
| Avery Therapeutics, Inc. | $8.5M | 23 | 506(b) | Sep 21, 2026 | 1 | direct |
| Continuity Biosciences, LLC | $8.4M | 13 | 506(b) | Aug 19, 2025 | 1 | direct |
| Repair Biotechnologies, Inc. | $8.4M | 38 | 506(b) | Jun 16, 2023 | 1 | direct |
| DermOQ, Inc. | $8.4M | 80 | 506(b) | Jan 8, 2025 | 1 | direct |
| Trace Biosciences Inc. | $8.3M | 19 | 506(b) | Aug 12, 2026 | 1 | direct |
| Inspira Technologies OXY B.H.N. Ltd | $8.3M | 12 | 506(b) | Jan 7, 2025 | 1 | direct |
| PATH EX, Inc. | $8.2M | 14 | 506(b) | May 9, 2025 | 1 | direct |
| California Cultured Inc. | $8.1M | 35 | 506(b) | Feb 10, 2026 | 2 | direct |
| FlightPath Biosciences, Inc. | $8.1M | 17 | 506(b) | Oct 24, 2024 | 2 | direct |
| RevOpsis Therapeutics, Inc. | $7.9M | 36 | 506(c) | Aug 10, 2023 | 1 | direct |
| TracerDX, Inc. | $7.9M | 18 | 506(b) | Aug 8, 2024 | 1 | direct |
| 3Helix, Inc. | $7.8M | 13 | 506(b) | Sep 21, 2026 | 1 | direct |
| Hopewell Therapeutics, Inc. | $7.8M | 8 | 506(b) | May 17, 2024 | 2 | direct |
| OXOS Series #7 Holdings, LLC | $7.8M | 79 | 506(b) | Jan 26, 2023 | 2 | direct |
| Pleural Dynamics, Inc. | $7.7M | 29 | 506(b) | Feb 4, 2025 | 4 | direct |
